Abstract
1R,25-Dihydroxyvitamin D3, the hormonally active form of vitamin D3, besides regulating the homeostasis of calcium and classical bone mineralization, also promotes cellular differentiation and induces some biological functions related to the immunological system. Extensive structure-function studies have shown that it is possible to modify the calcitriol structure to obtain vitamin D3 analogs that are capable of inducing, in a selective manner, the biological functions related to the same hormone. In this article, we revised QSAR studies with conceptual parameters such as flexibility of rotation, probability of availability, etc. we then used the method of regression analysis and QSAR studies in order to understand the essential structural requirement for binding with receptor. Next, we reviewed Radial Distribution Function, 4DQSAR, CoMFA and Docking with different compounds to find out the structural requirements for GSK-3 inhibitory activity.
Keywords: QSAR, COMFA, docking, vitamin D3, calcitriol, Drosophila melanogaster, Nuclear Receptor, DNA Binding Receptor, trans-amide bond., metabolic stability, Radial Distribution Function, Multiple Linear Regression, Genetic Algorithm, TR1 ligands
Current Bioinformatics
Title: Trends in Bioinformatics and Chemoinformatics of Vitamin D Analogs and Their Protein Targets
Volume: 6 Issue: 1
Author(s): Isela García, Yagamare Fall and Generosa Gomez
Affiliation:
Keywords: QSAR, COMFA, docking, vitamin D3, calcitriol, Drosophila melanogaster, Nuclear Receptor, DNA Binding Receptor, trans-amide bond., metabolic stability, Radial Distribution Function, Multiple Linear Regression, Genetic Algorithm, TR1 ligands
Abstract: 1R,25-Dihydroxyvitamin D3, the hormonally active form of vitamin D3, besides regulating the homeostasis of calcium and classical bone mineralization, also promotes cellular differentiation and induces some biological functions related to the immunological system. Extensive structure-function studies have shown that it is possible to modify the calcitriol structure to obtain vitamin D3 analogs that are capable of inducing, in a selective manner, the biological functions related to the same hormone. In this article, we revised QSAR studies with conceptual parameters such as flexibility of rotation, probability of availability, etc. we then used the method of regression analysis and QSAR studies in order to understand the essential structural requirement for binding with receptor. Next, we reviewed Radial Distribution Function, 4DQSAR, CoMFA and Docking with different compounds to find out the structural requirements for GSK-3 inhibitory activity.
Export Options
About this article
Cite this article as:
García Isela, Fall Yagamare and Gomez Generosa, Trends in Bioinformatics and Chemoinformatics of Vitamin D Analogs and Their Protein Targets, Current Bioinformatics 2011; 6 (1) . https://dx.doi.org/10.2174/157489311795222383
DOI https://dx.doi.org/10.2174/157489311795222383 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Frailty Among Alzheimer’s Disease Patients
CNS & Neurological Disorders - Drug Targets New Insights on the Beneficial Effects of the Probiotic Kefir on Vascular Dysfunction in Cardiovascular and Neurodegenerative Diseases
Current Pharmaceutical Design Mechanisms of Renal Microvascular Dysfunction in Type 1 Diabetes: Potential Contribution to End Organ Damage
Current Vascular Pharmacology Proteinase-Activated Receptor 2 (PAR2): A Challenging New Target for Treatment of Vascular Diseases
Current Pharmaceutical Design The Breath of Life: Recent Patents on Placental and Amnion Derived Cells for Treatment of Bronchopulmonary Dysplasia
Recent Patents on Regenerative Medicine New Approaches in the Diagnosis of Atherosclerosis and Treatment of Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery Herb-drug Interactions Involving Drug Metabolizing Enzymes and Transporters
Current Drug Metabolism Characterization and Antihypertensive Effect of the Complex of (-)-β- pinene in β-cyclodextrin
Current Pharmaceutical Biotechnology Relevance of the Vascular Effects of Insulin in the Rationale of its Therapeutical Use
Cardiovascular & Hematological Disorders-Drug Targets The Effects of Hemocoagulase on Coagulation Factors in an Elderly Patient with Upper Gastrointestinal Hemorrhage: A Case Report
Current Drug Safety Therapeutic Perspectives on Pancreatic Cancer
Current Cancer Drug Targets Neuroimmune Aspects of Sjogren`s Syndrome: Role of VIP/VPAC System in Immune and Salivary Gland Epithelial Cell Function
Current Pharmaceutical Design Biomarkers in Lone Atrial Fibrillation-An Additional ‘Fine Tuning’ of Risk?
Current Pharmaceutical Design Estrogen Regulation of MicroRNA Expression
Current Genomics Mitochondria-Targeted Drugs
Current Molecular Pharmacology Efficacy and Adverse Effects of Venlafaxine in Children and Adolescents with ADHD: A Systematic Review of Non-controlled and Controlled Trials
Reviews on Recent Clinical Trials The Use of Dexmedetomidine in Anesthesia and Intensive Care: A Review
Current Pharmaceutical Design Common Variant in VEGFA and Response to Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration
Current Molecular Medicine Mechanisms of Esophageal Protection, Gastroprotection and Ulcer Healing by Melatonin. Implications for the Therapeutic use of Melatonin in Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease
Current Pharmaceutical Design Anti-Diabetic Compounds and their Patent Information: An Update
Recent Patents on Inflammation & Allergy Drug Discovery